Scientific Programme - Accredited | Société Internationale d'Urologie

2022 Congress Learning Objectives:

After this educational event, attendees should be able to:

Understand the latest advances in the diagnosis, staging and management of urologic cancers.
Incorporate new techniques in robotic and minimally invasive surgery.
Detail the medical and surgical management of lower urinary tract dysfunction.
Describe the evaluation and medical and surgical therapy of urinary stone disease.
Define the assessment and management of male infertility.
Characterize the surgical and medical treatment options for erectile dysfunction.
See the latest advances in reconstructive surgery including transgender surgery, urinary diversion and urethroplasty.
Learn how to serve the diverse healthcare needs of our international population in a patient-centered manner.
Learn the latest urologic sub-specialty advances occurring in the past year to augment one’s practice.
Provide mentoring sessions to facilitate knowledge about career opportunities and advancement for urology trainees.
Enumerate common urological problems of the elderly and specific precautions in their care.
Identify congenital urological diseases and discuss approach to their management.
Develop a skillset for the management of complex urinary tract infections.

SIU 2022 Scientific Programme - Accredited*

*SUBJECT TO CHANGE

All session times are listed in Eastern Time (ET).

To view the PDF version of the Scientific Programme, please click here.

REGISTER NOW

Wednesday, November 09

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0800-1730		Wednesday Unaccredited Sessions - View Sessions Room: To be announced
		To view the Wednesday, November 9 unaccredited Scientific Programme, please visit: https://www.siu-urology.org/congress-2022/unaccredited-activities

Thursday, November 10

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-1500

LS: Semi-Live Surgery

Room: 517 A
Co-Chairs: Mélanie Aubé-Peterkin, Canada / Jean de la Rosette, Türkiye / Rafael Sanchez-Salas, Canada

0800-0930

IC-01: Instructional Course: Evaluation and Management of Non-neurogenic Female Bladder Outlet Obstruction (BOO)

Room: 519 A
Chair: Lysanne Campeau, Canada

0800-1000

IS-01: Interactive Session: Bladder Pain Syndrome and Interstitial Cystitis

Room: 524 C
Co-Chair: Rajesh Taneja, India

0800-1000

TIPS-01: SIU Tips and Tricks - Pt 1 SIU Academy

Room: 524 B
Chair: Mauro Gacci, Italy

0800-0803		Welcome and Introductions
0803-0827		The Impact of the COVID-19 Pandemic on Urological Training
		Urologist Perspective Petros Sountoulides, Greece
		Trainee Perspective Benjamin Legault, Canada
0827-0839		Simulators in Urology: Applications and Limitations Arvind Ganpule, India
0839-0851		The Pandemic and Delays in Fertility Care: Lessons Learned Sarah Vij, United States
0851-0903		The Pandemic and Delays in Oncologic Care: Lessons Learned Evan Kovac, United States
0903-0915		Virtual Training and Outreach Programs: Endless Possibilities Rajeev Sood, India
0915-0927		SIU Scholarships and Training Opportunities Pilar Laguna, Türkiye
0927-1000		Panel Discussion

0800-1000

SYMP-10: Symposium: Canadian Urological Association (CUA)

Room: 518 A
Co-Chairs: Armen Aprikian, Canada / Ricardo Rendon, Canada

0800-0805		Welcome and Introductions
0805-0825		Germline predisposition and clinical implications William Foulkes, Canada
0825-0845		Bladder Cancer - Lecture title TBC Peter Black, Canada
0845-0905		PARP Inhibitors in Prostate Cancer: Why, When, and in Who? Fred Saad, Canada
0905-0925		Kidney Cancer - Lecture title TBC Simon Tanguay, Canada
0925-0955		Case Presentations and Panel Discussion Andrea Kokorovic, Canada
0955-1000		Closing Remarks

0800-1000

WS-01: Workshop: Basics in Endourology (For Beginners)

Room: 522 ABC
Co-Chair: Dilip Mishra, India

0800-1200

SYMP-11: Symposium: Joint International Society of Reconstructive Urology (ISORU) & Society of Genitourinary Reconstructive Surgeons (GURS)

Room: 520 CF
Co-Chairs: Sean P. Elliott, United States / Pankaj Joshi, India / Sanjay Kulkarni, India / Ramon Virasoro, United States

0800-1200

SYMP-12: Symposium: International Consultation on Urological Diseases (ICUD) and World Urologic Oncology Federation (WUOF) - Consultation: Kidney Cancer

Room: 524 A
Chair: Laurence Klotz, Canada

1000-1130

IC-03: Instructional Course: Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)

Room: 518 B
Chair: Dean Elterman, Canada

1000-1130

IC-04: Instructional Course: Testosterone Replacement Therapy: An Update on What You Need to Know for Safe Prescribing in Men with Pre-existing Prostate and Cardiovascular Disease and the Impact of COVID-19

Room: 519 B
Chair: Brian Birch, United Kingdom

1000-1200

IS-02: Interactive Session: Medico-Legal Aspects in Urology: Global Challenges

Room: 524 C
Co-Chairs: Joe Philip, United Kingdom / Rajeev T P, India

1000-1200

TIPS-02: SIU Tips and Tricks - Pt 2 SIUJ - Tips & Tricks in Urologic Publishing

Room: 524 B
Chair: Peter Black, Canada

1000-1200

SYMP-13: Symposium: French Urology Around the World (en français)

Room: 518 C
Moderators: Georges Fournier, France / Alain Maillette, Canada

1000-1005		Mot de bienvenu
		Les biopsies de la prostate revisitées : 30’
1005-1025		La fusion d’images : Est-ce un réel bénéfice ? Pour: Pierre Mozer, France Contre: Patrick Richard, Canada
1025-1045		Voies d’abord : est-ce la fin de la voie transrectale ? Pour: Maurice Anidjar, Canada Contre: Franck Bladou, France
1045-1055		Discussion
		Nouveautés dans le traitement de l’HBP : 30’
1055-1105		Techniques de préservation de l’éjaculation Grégoire Robert, France
1105-1115		Résultats des différentes techniques minimalement-invasives Mélanie Aubé-Peterkin, Canada
1115-1125		Discussion
		Endo-urologie
1125-1135		Quel laser choisir en 2022 ? Steeve Doizi, France
1135-1145		Les endoscopes jetables : Est-ce une solution viable ? Naeem Bhojani, Canada
1145-1155		Discussion
1155-1200		Mot de la fin

1000-1200

SYMP-14: Symposium: Joint SIU / Confederación Americana de Urología (CAU) (in English)

Room: 518 A
Co-Chairs: Reynaldo Gómez, Chile / Rafael Sanchez-Salas, Canada

1000-1200

WS-02: Workshop: Laparoscopy for Beginners

Room: 520 A
Co-Chairs: Bhavan Rai, United Kingdom / Rajan Veeratterapillay, United Kingdom
Faculty: Zeeshan Aslam, United Kingdom / Gabriela Caballero, Mexico / Jose Antonio de Jesus Martinez Garcia, Mexico / Karthickeyan Naganathan, India / Arjun Nambiar, United Kingdom

1000-1010		Welcome and Introductions Bhavan Rai, United Kingdom
1010-1030		Equipment Rajan Veeratterapillay, United Kingdom
1030-1050		Task-1: Peg-Transfer
1050-1110		Task-2: Cutting the Circle
1050-1125		Task-3: Needle Driving
1110-1150		Task-4: Suturing
1150-1200		Feedback

1000-1200

SYMP-15: Symposium: Joint SIU / Korean Urological Association (KUA)

Room: 519 A
Co-Chairs: Christopher Evans, United States / Sung Kyu Hong, South Korea

1215-1315

SYMP-16: Luncheon Symposium - What Is the Role of Immunotherapy in NMIBC/MIBC? Perspectives from a Multidisciplinary Team

Room: 517 B
Chair: Srikala Sridhar, Canada

1300-1430

IC-05: Instructional Course: Varicocele and Male Infertility: Uncovering the Facts by an Evidence Based Approach

Room: 519 B
Chair: Ashok Agarwal, United States

1300-1315		Mechanisms of varicocele-mediated male infertility: Role of oxidative stress, sperm DNA fragmentation, proteomics, epigenetics and genetics Ashok Agarwal, United States
1315-1330		The best treatment option of infertile men with varicocele: Medical, surgical or ART? Hussein Kandil, United Arab Emirates
1330-1345		How to manage infertile men with varicocele associated with non-obstructive azoospermia? Ramadan Saleh, Egypt
1345-1400		Consensus and Diversity in the management of infertile men with varicocele: Results of global practice survey Rossella Cannarella, United States
1400-1430		Moderated Session: Questions & Answers

1300-1430

IC-06: Instructional Course: Virtual Care, TeleUrology, Digital Health - Full Complement of Patient-Centred Urologic Care: The Time Is Now!

Room: 524 B
Chair: Emmanuel Abara, Canada

1300-1303		Welcome and Introduction Emmanuel Abara, Canada
1303-1315		Where did we come from? Where are we? Where are we heading to? Emmanuel Abara, Canada
1315-1319		Q&A
1319-1331		What do our patients need or want? What can we offer them? Where is the balance? A role for Guidelines appropriate with resources? Aaron D. Martin, United States
1331-1335		Q&A
1335-1347		What Regulatory Processes, Legal Aspects, Policy Affairs and Re-imbursement 'hurdles' should we be aware of? Aaron D. Martin, United States
1347-1351		Q&A
1351-1403		Teleurology Implementation: Practical Points, Different Places and Perspectives? Emmanuel Abara, Canada Mohamed Jalloh, Senegal
1403-1407		Q&A
1407-1419		What are the Challenges and Opportunities for Virtual Care. TeleUrology. Digital Health: Now and Going Forward? Emmanuel Abara, Canada
1419-1423		Q&A
1423-1430		Summary / Take Home Message

1300-1500

IS-03: Interactive Session: Global Young Consultants Forum: Shaping your Urology Career

Room: 524 A
Co-Chair: Gabriela Caballero, Mexico

1300-1305		Welcome and Introductions
1305-1315		Burnout Among Young Urologists: How to Circumvent Vikram Sridharan, India
1315-1325		Subspecialty Training in Urology: Where Do We Stand? Rohit Joshi, India
1325-1335		Artificial Intelligence Made Simple for Urologists R B Nerli, India
1335-1345		Setting Up a Specialty Clinic Saeed Bin Hamri, Saudi Arabia
1345-1355		Thulium Laser Fiber and Disposable Ureteroscope: My Armamentarium for Renal Stone Disease Syed Zahid Raza, India
1355-1405		Future of Ureteric Stents Fadl Hamouche, Canada
1405-1415		How to Approach a PFUD Rishi Nayyar, India
1415-1425		Laparoscopy Learning Curve and Will it Replace Open Technique Rajan Veeratterapillay, United Kingdom
1425-1455		Interactive Panel
1455-1500		Closing Remarks

1300-1500

MV-01: Master Videos: Complications in Minimally Invasive Urology and How to Handle?

Room: 522 ABC
Co-Chairs: Greg Boustead, South Africa / Ravindra Sabnis, India

1300-1500

SYMP-17: Symposium: Joint SIU / European Association of Urology (EAU)

Room: 520 CF
Co-Chairs: Christopher R Chapple, United Kingdom / Christopher Evans, United States

1300-1500

IS-04: Interactive Session: Recurrent UTIs

Room: 524 C
Chair: Bhaskar K. Somani, United Kingdom

1300-1500

SYMP-18: Symposium: International Neuro-Urology Society (INUS)

Room: 518 C
Co-Chairs: Howard Goldman, United States / Blayne Welk, Canada

1300-1500

IS-05: Interactive Session: Women in Urology - Leading the Way!

Room: 518 A
Co-Chairs: Jean McDonald, United Kingdom / G G Laxman Prabhu, India

1300-1700

SYMP-20: Symposium: Focal Therapy for Renal and Prostate Cancers

Room: 519 A
Co-Chairs: Jurgen Fütterer, The Netherlands / Rafael Tourinho-Barbosa, Brazil

1500-1700

WS-03: Workshop: Basics on USG in Urology

Room: 520 B
Chair: Ravindra Sabnis, India
Faculty: Chandrasekharan Badrakumar, United Kingdom / Arvind Ganpule, India

1500-1630

TIPS-03: SIU Tips and Tricks - Pt 3 SIU uCare

Room: 524 B
Co-Chairs: Ranan Dasgupta, United Kingdom / Mihir Desai, United States

1500-1630

IC-07: Instructional Course: Overcoming Access and Quality Barriers in Cancer Care using Disruptive Health Technologies

Room: 519 B
Chair: Shaheen Alanee, United States

1500-1515		Challenges in Delivering Cancer Care to Rural and Disadvantaged Communities in the U.S. Shaheen Alanee, United States
1515-1532		Leading a City-based Partnership Initiative that Aims to Improve Access to Quality Cancer Care in Cities Around the World Mathieu Morand, Switzerland
1532-1549		Digital Transformation and Disruptive Health-Tech Nur Alkhateeb, United Kingdom
1549-1606		Real World Evidence – Companies, Academics, and Health Professional Working Together
1606-1630		Group Discussion

1500-1630

IC-08: Instructional Course: Advanced Ureteroscopy

Room: 524 C
Chair: Michael Grasso, United States

1500-1700

HT-01: Hot Topics: Modern Endourological Avenues for Urologists

Room: 524 A
Co-Chairs: Madhu Sudan Agrawal, India / Ben Chew, Canada

1500-1700

MV-02: Master Videos: Recent Innovations in Transurethral Techniques for Resection of Bladder Tumor

Room: 522 ABC
Co-Chairs: José Luis Domínguez-Escrig, Spain / Badrinath Konety, United States

1500-1700

SYMP-21: Symposium: Hellenic Urological Association (HUA)

Room: 518 C
Co-Chairs: Alivizatos Gerasimos, Greece / Ioannis Gkialas, Greece

Friday, November 11

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-0900

MC-01: Master Class: Coping with the Dearth of Organs in Renal Transplantation

Room: 518 A
Co-Chairs: Patrick Luke, Canada / Alp Sener, Canada

0730-0743		Overview of the Global Organ Shortage Pawan R Chalise, Nepal The demand for organ transplantation has rapidly increased all over the world due to the increase in the incidence of vital organ failure, the rising success, and greater improvement in post-transplant outcomes. However, the unavailability of adequate organs for transplantation to meet the existing demand has resulted in major organ shortage crises. As a result, there has been a major increase in the number of patients on transplant waiting lists as well as in the number of patients dying while on the waiting list. We have been exploring ways to increase the supply of donor organs to meet the challenge of increasing waiting lists and deaths.
0743-0756		Donor with Renal Cysts Tips and Tricks on Evaluation and Use Aneesh Srivastava, India Ravine et.al in 1994 suggested the ultrasound based criteria to suggest the possibility of ADPKD in the potential donor from the family where the recipient had ESRD due to ADPKD and the same were being followed for last couple of decades. Controversies surrounded another common situation where the potential donor was incidentally found to have multiple cysts during the process of evaluation without any family history as there were no clear guidelines. Evolution in the better understanding of the molecular mechanisms, genetics and the natural history of the cystic disease along with improvements in the imaging technologies has led to modifications in the investigative protocols in such situations.
0756-0809		Donor with Stone Disease: Contemporary Management Options P P SINGH, India Incidental detection of Stone disease in a potential donor poses several questions before the transplant team and it is more or less same if he has a past history of stone formation and treatment.
0809-0822		Current State of Affairs in Paired Exchange Kidney Transplantation Puneet Sindhwani, United States With the growing number of patients being added to the kidney transplant wait list globally, there is an increasing gap with the number of available organs for transplantation. Many programs have implemented paired exchange programs to meet the supply and demand challenge. These various methods will be reviewed.
0822-0835		Expanded Use of Marginal Cadaveric Renal Grafts Patrick Luke, Canada
0835-0900		Discussion and Q&A

0730-0900

HT-02: Hot Topics: Rapid Fire Session

Room: 524 A
Co-Chairs: Marc Dall'Era, United States / Li-Ping Xie, People's Republic of China

0730-0900

IC-09: Instructional Course: Endoscopic Combined Intra Renal Surgery (ECIRS)

Room: 524 B
Chair: Madhu Sudan Agrawal, India

0730-0735		Welcome and Introductions Madhu Sudan Agrawal, India
0735-0750		Didactic Lecture on Indications of ECIRS, the Equipment, Positioning and OR Arrangement for ECIRS Dilip Mishra, India
0750-0805		Didactic Lecture and Videos on How to Puncture in Supine Position; Use of Ultrasound, Fluoroscopy and Endoscopic Guidance for Puncture Madhu Sudan Agrawal, India
0805-0820		Point-of-technique Videos on Technique of ECIRS, including Various Manoeuvres Like ‘passing The Ball’ Manoj Monga, United States
0820-0835		Literature Review, Outcome Analysis on ECIRS, Comparison with other Endourological Procedures (MPCNL, RIRS alone) Bhaskar K. Somani, United Kingdom
0835-0900		Interactive Case Based Discussions and Q/A Session

0730-0900

IC-10: Instructional Course: Sexual Recovery after Radical Prostatectomy

Room: 524 C
Chair: Brian Miles, United States

0730-0900

MC-02: Master Class: Genitourinary Trauma

Room: 518 B
Co-Chairs: Zeeshan Aslam, United Kingdom / M Hammad Ather, Pakistan

0730-0733		Introduction Faysal Yafi, United States
0733-0745		Management of Blunt Renal Trauma: Imaging Protocols and Indications for Surgical Exploration M Hammad Ather, Pakistan
0745-0749		Q&A
0749-0801		Management of Bladder Trauma - Diagnostic Evaluation and Management Options Medina Ndoye, Senegal
0801-0805		Q&A
0805-0817		Penile fracture: Indications for Imaging and Principles of Management Harprit Singh, India
0817-0821		Q&A
0821-0833		Management of Latrogenic Ureteral Injuries and Principles of Surgical Repair Evelyn Mmapula Moshokoa, South Africa
0833-0837		Q&A
0837-0849		Classification and Management of Urethral Injuries Associated with Pelvic Fractures Jay Simhan, United States
0849-0853		Q&A
0853-0857		Additional Questions from Audience
0857-0900		Conclusions and Take Home Message Zeeshan Aslam, United Kingdom

0730-0900

MC-03: Master Class: Germline Mutations in Urologic Cancers

Room: 518 C
Co-Chairs: Leonard Gomella, United States / Gokul Vignesh KandaSwamy, United Kingdom

0800-1715

B2B: Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting

Room: 517 B
Co-Chairs: Peter Black, Canada / Alexandra Masson-Lecomte, France / Simon Tanguay, Canada / Derya Tilki, Germany

0900-1030

PL-01: Plenary 01

Room: 517 A
Honorary Chairs: Christopher Evans, United States / Reynaldo Gómez, Chile / Rajeev T P, India

0900-0905		Welcome
0905-0910		Introduction to SIU-Mostafa M. Elhilali Award Lecture
0910-0925		SIU-Mostafa M. Elhilali Award Lecture - Co-Targeting Genomic Drivers of Resistance in Prostate Cancer – Evolving Towards Precision Oncology Martin Gleave, Canada
0925-0940		Canadian Urological Association (CUA) lecture: Nuances of Treating Bladder Cancer Variants Wassim Kassouf, Canada Learning Objectives: At the end of this lecture, attendees will be able to: Describe common histologic variants in bladder cancer Highlight challenges in diagnosis of variant histology Outline management of different histologic variants
0940-0955		Pan African Urological Surgeons Association (PAUSA) Lecture: Urological practices in Africa: Navigating Through the Obstacles of Customs and Traditional Beliefs Alexander M.E. Nwofor, Nigeria Learning Objectives: At the end of this lectures, attendees will: Learn how to serve the diverse healthcare needs of our international population in a patient-centered manner across different cultures especially in the developing countries. Provide mentoring sessions to facilitate knowledge about career opportunities and advancement for urology trainees and practitioners especially in SubSaharan Africa.
0955-1010		State of the Art Lecture: Making ECIRS Inexpensive and Labour Efficient! Madhu Sudan Agrawal, India Learning Objectives: At the end of the lecture, attendees will be able to: Understand the indications of concurrent supine PCNL and fURS to improve the stone-free rates with reduced morbidity. Learn how to position a patient in modified supine position for ECIRS. Learn how to perform successful access in supine PCNL by own self, using fluoroscopic and ultrasonic – guided puncture (rather than being dependent on the radiologist). Understand how to combine the benefits of Mini-PCNL and fURS in the minimally-invasive way, making it inexpensive and labour-efficient.
1010-1020		State of the Art Lecture: Transperineal Biopsy as the New Standard of Care Marc Dall'Era, United States
1020-1025		Discussion: How to Set up a High Volume Daycare TP Biopsy Under Local Anaesthetic Panelists Marc Dall'Era, United States Bhavan Rai, United Kingdom Rajan Veeratterapillay, United Kingdom
1025-1030		Closing Remarks

1030-1100

Break

Room: To be announced

1045-1245

IS-06: Interactive Session: Men's Health - Growing Concerns

Room: 522 ABC
Co-Chairs: Jean de la Rosette, Türkiye / Rajeev Sood, India

1100-1230

HT-03: Hot Topics: Advanced Imaging and Its Impact on Staging and Treatment of Urologic Cancers

Room: 524 A
Co-Chairs: Sanjai Addla, India / M Hammad Ather, Pakistan

1100-1105		Welcome
1105-1116		VI-RADS in Bladder Cancer MRI Ronald Kool, Canada
1116-1121		Q&A
1121-1132		Role of PSMA PET Scan in Prostate Cancer Sanjai Addla, India
1132-1137		Q&A
1137-1148		Role of Contrast Enhanced Ultrasound in Renal Masses M Hammad Ather, Pakistan
1148-1153		Q&A
1153-1204		Role of MRI in Penile Cancer Rakesh Manilal Sharma, India
1204-1209		Q&A
1209-1220		Use of PET CT in Testicular Cancer Kinju Adhikari, Nepal/India
1220-1225		Q&A
1225-1230		Concluding Remarks

1100-1230

IS-07: Interactive Session: Social Media and its Role in Urological Practice

Room: 524 B
Co-Chairs: Justin Dubin, United States / Michael Leveridge, Canada

1100-1230

JS-01: Joint Session: SIU / Endourological Society

Room: 519 B
Co-Chairs: Naeem Bhojani, Canada / Kymora Scotland, United States
Honorary Co-Chair: Rajeev T P, India

1100-1230

MC-04: Master Class: Congenital Dilated Ureter

Room: 518 C
Co-Chairs: Margit Fisch, Germany / Anil Takvani, India

1100-1230

MC-05: Master Class: Female Urinary Fistulae

Room: 518 B
Chair: Sanjay Sinha, India

1100-1105		Welcome and Introductions Sanjay Sinha, India
1105-1119		Contemporary Management of Obstetric Urinary Fistulae Medina Ndoye, Senegal
1119-1133		Contemporary Management of Non-Obstetric Urinary Fistulae Lalit Shah, India
1133-1147		What the West Can Learn from the Experience of Developing Nations in Urinary Fistula Management ? Igor Vaz, Mozambique
1143-1157		MDT - Difficult Cases of Female Urinary Fistulae Serigne Magueye Gueye, Senegal
1153-1230		Discussion and Q&A / Closing Remarks Sanjay Sinha, India

1100-1230

MC-06: Master Class: The New WHO Manual (6th Edition) for Semen Analysis: What Does it Mean for the Urologist?

Room: 518 A
Chair: Ashok Agarwal, United States

1100-1115		Basic Semen Examination for the Clinician: Indications and Clinical Decision Thresholds in Infertile Men Hussein Kandil, United Arab Emirates
1115-1130		Sperm DNA Fragmentation Test from Research Bench to Clinical Practice Ramadan Saleh, Egypt
1130-1145		The Concept of Seminal Oxidative-reduction Potential for Clinicians: Indications and Clinical Decision Thresholds in Infertile Men. Ashok Agarwal, United States
1145-1200		SWOT Analysis of the WHO 6th Edition of Human Semen Analysis Rossella Cannarella, United States
1200-1230		Moderated Session: Questions & Answers

1100-1230

WS-04: Workshop: Transperineal and Fusion Prostate Biopsy – Advantages and Techniques

Room: 520 A
Co-Chairs: Marc Dall'Era, United States / Rajan Veeratterapillay, United Kingdom
Faculty: Franck Bladou, France

1100-1230

JS-02: Joint Session: SIU / International Society of Reconstructive Urology (ISORU)

Room: 520 CF
Co-Chairs: Kuncoro Adi, Indonesia / Pankaj Joshi, India

1230-1400

Networking Lunch

Room: Exhibit Hall 517 CD

1245-1400

SYMP-22: Luncheon Symposium - Clinical Pathway of BPH: Optimizing Treatment-Decision Making and Patient Care

Room: 519 A
Chair: Stavros Gravas, Cyprus
Faculty: Naeem Bhojani, Canada / Neal Rowe, Canada / Silvia Secco, Italy

1400-1530

HT-04: Hot Topics: Application of AI and its Scope in Urology

Room: 524 A
Co-Chairs: Belthangady Monu Zeeshan Hameed, India / Bhavan Rai, United Kingdom

1400-1530

IC-12: Instructional Course: Managing Male Infertility in the IVF Era: Sperm Matter More Than Ever!

Room: 520 CF
Chair: Paul Turek, United States

1400-1530

IS-08: Interactive Session: Management of Advanced Prostate Cancer

Room: 524 B
Co-Chairs: Mihir Desai, United States / Shomik Sengupta, Australia

1400-1405		Welcome and Introductions
1405-1417		Prostate Cancer - Molecular Biology Made Simple Amina Zoubeidi, Canada
1417-1429		Management of Locally Advanced Prostate Cancer (T3/4, cN+, margin positive surgery) Rajeev Sood, India
1429-1441		Role of Local Therapy (Radiation or Surgery) in Oligometastatic Prostate Cancer Brian F Chapin, United States
1441-1453		Systemic Therapy Options in HSPC & CRPC Shilpa Gupta, United States
1453-1505		Place of Bilateral Orchidectomy in the Present Era NItesh Jain, India
1505-1530		Discussion and Q&A

1400-1530

MV-03: Master Videos: Surgery and Procedures for Stress and Urge Incontinence in Females

Room: 518 A
Co-Chairs: Priyanka Gupta, United States / Anita Patel, India

1400-1530

MP-01: Moderated ePoster Session - Basic Science - Benign Diseases, Infections and Inflammatory Diseases, Kidney and Ureter, Benign Diseases, Minimally Invasive Surgery/Robotics, Training and Education, Miscellaneous

Room: 518 B
Moderator: Emmanuel Abara, Canada

MP-01.01 Comparison of Urgent Decompression for Severe Urinary Tract Infection in Obstructive Urolithiasis: an Updated Systematic Review and Meta-Analysis
Jae Yong Jeong Korea, Rep.

MP-01.02 Conversion Rate of Abstracts Presented at the Société Internationale D'urologie Into Peer-reviewed Journal Publications
Amandeep Virk, Australia

MP-01.03 Diagnostic and Therapeutic Role of Retrograde Intrarenal Surgery in Diabetic Papillary Necrosis
Karthickeyan Naganathan, India

MP-01.04 Incremental Change in X-ray and Operative Time for Ureteric Stent Insertion During the First Six Months of Training in an Australian Public Hospital
Kireeti Chigurala, Australia

MP-01.05 Medical-grade Manuka Honey Inhibits Mast Cell Degranulation Through Downregulation of the PI3K/Akt Signalling Pathway: Potential Intravesical Agent in the Management of Interstitial Cystitis/bladder Pain Syndrome?
Brian Birch, United Kingdom

MP-01.06 Nitric Oxide Secretion Regulates Levels of Ngf in Bladder Cells in Vitro
Lysanne Campeau, Canada

MP-01.07 Prevalence of the Clavien Dindo Classification in the Reporting of Surgical Complications in Major Urological Journals
Amandeep Virk, Australia

MP-01.08 Prostate Volume and Number of Injections Predict Improvement in Erectile Function but Not Ejaculatory Function in Men Treated with Rezum Convective Water Vapour Therapy
Dean Elterman, Canada

MP-01.09 Raised Intrarenal Pressure and Mechanisms of Infection: an Ex Vivo Animal Model
Anne Hong, Australia

MP-01.10 Regional Variations in the Uropathogen Microbiome - Are the Current Australian Empirical Antimicrobial Guidelines Appropriate?
Gavin Wei, Australia

MP-01.11 Small Angiomyolipoma, when It is Safe to Discharge?
Ali Al-Gonaim, Saudi Arabia

MP-01.12 Use of Artificial Intelligence Comparative to Humans to Estimate Surgical Procedure Duration for Urological Procedures. Preliminary Results
Rodrigo Ketzer Krebs, Brazil

MP-01.13 Utilization of Telemedicine in Cancer Patients: an Analysis of the National Health Interview Survey Data in the Covid-19 Era
Khalid Alkhatib, United States

MP-01-14 Learner-Driven Telemedicine Curriculum During Covid-19 Pandemic
Emmanuel Abara, Canada

MP-06.10 Pre-operative Images for Upper Tract Stones - How Old is Too Old?
Ijeoma Chibuzo, United Kingdom

MP-01.15 Urinary Markers of Renal Injury During Narrow Focus versus Wide Focus Shock Wave Lithotripsy in Management of 1-2cm Renal Calculi Using Tri-focal Lithotripsy Machine: First Double-blind Randomized Trial
Yasser Noureldin, Saudi Arabia

MP-02.13 Vessel-Sparing Anastomotic Reconstruction of the Posterior Urethra: Single Center Experience with Long-Term Follow-Up
Reynaldo G. Gomez, Chile

1400-1530

MVP-01: Moderated Video ePoster Session - Kidney and Ureter, Benign Diseases, Reconstruction, Stones, Training and Education

Room: 518 C
Moderators: Ananda Dhanasekaran, United Kingdom / Harprit Singh, India

1400-1530

IS-09: Interactive Session: Update on NMIBC

Room: 524 C
Co-Chairs: E. Oluwabunmi Olapade-Olaopa, Nigeria / Sudhir Rawal, India

1415-1715

INN-01: SIU Innovators

Room: 522 ABC
Co-Chairs: Kelly Bree, United States / Wei Shen Tan, USA

1530-1600

Break

Room: To be announced

1600-1730

SYMP-23: Symposium: International Society for Sexual Medicine (ISSM)

Room: 524 A
Chair: Gerald Brock, Canada

1600-1605		Welcome Gerald Brock, Canada
1605-1616		Case Study 1 – Prosthetics - Role Of Antibiotics, Length Optimization, Reservoir Location
1616-1624		Discussion/Q&A (including literature recommendations)
1624-1635		Case Study 2 – Consent Issues, Partner Involvement, Status Post-priapism, Failed Device, Infection
1635-1643		Discussion/Q&A (including literature recommendations)
1643-1654		Case Study 3 – Priapism, Management, Strategies For Implants, Timing, Device Choice, Approach
1654-1702		Discussion/Q&A (including literature recommendations)
1702-1713		Cast study 4 – Intraoperative Complications - Vascular Injury, Urethral Injury, Cross-over, Perforation Prox/Distal, Revision-loss of Original Reservoir
1713-1721		Discussion/Q&A (including literature recommendations)
1721-1730		Conclusions

1600-1730

CO-01: Controversies in Urology: Female LUTS

Room: 519 B
Co-Chairs: Arjun Nambiar, United Kingdom / Sanjay Sinha, India

1600-1730

IS-10: Interactive Session: Sacral Neuromodulation - Tips and Tricks

Room: 524 B
Co-Chairs: Jennifer Rothschild, United States / Alan Wein, United States

1600-1730

IS-11: Interactive Session: Surgical Interventions for Various Urinary Fistulae

Room: 524 C
Co-Chairs: Reynaldo Gómez, Chile / Sanjay Pandey, India

1600-1730

MV-04: Master Videos: Tips and Tricks - Robotic Partial Nephrectomy

Room: 518 A
Co-Chairs: Raghunath Krishnappa, India / Ricardo Rendon, Canada

1600-1605		Welcome and Introductions
1605-1618		Partial Nephrectomy for Beginners Ginil Kumar, India
1618-1631		Robotic Partial Nephrectomy for Complex Tumors Raghunath Krishnappa, India
1631-1644		Training Curriculums and Simulation Based Training in Robotic Partial Nephrectomy Ricardo Rendon, Canada
1644-1657		Dealing with intra-operative complications Wooju Jeong, United States
1657-1730		Discussion and Q&A / Closing Remarks

1600-1730

MP-02: Moderated ePoster Session - Reconstruction, Miscellaneous

Room: 518 B
Moderators: Kurt McCammon, United States / Karthickeyan Naganathan, India

1600-1730

MP-03: Moderated ePoster Session - BPO/LUTS, Female Urology, Infertility, Pediatric Urology, Renal Transplantation, Sexual Dysfunction

Room: 518 C
Moderators: Lysanne Campeau, Canada / Sang Don Lee, South Korea

MP-03.01 A Single-Center Prospective Cohort Study on First-Morning Urine Osmolality Change in Nocturnal Enuresis
Jae Min Chung, Korea, Rep.

MP-03.02 Ability and Accuracy of the Smartphone-based O`view-m® Sperm Test: Useful Tool Iot Device for Measurement for Semen
Younghun Sim, Korea, Rep.

MP-03.03 Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150cc): 4-Year Results
Naeem Bhojani, Canada

MP-03.04 Comparative Analysis of MOSES Technology versus Novel Thulium Fiber Laser for Transurethral Enucleation of the Prostate: a Single-institution Study
Loay Abbas, Canada

MP-03.05 Contemporary Series on Urethral Diverticulectomy - a 20-year Single-centre Experience
Arthur Yim, Australia

MP-03.06 Emergency Holmium Laser Enucleation of the Prostate (HoLEP): a Novel Approach in the Management of Refractory Hematuria of Prostatic Origin
Loay Abbas, Canada

MP-03.07 Erogenous Zones of the Vagina: an Anatomic Map-Based Study
Jenna Stelmar, United States

MP-03.08 In the Era of Computed Tomography Volumetry: is Isotope Renography Still Routinely Required in the Preparation and Selection of Living Kidney Donors?
Bedeir Ali-El-Dein, Egypt, Arab Rep.

MP-03.09 Increased Urinary Ratio Bdnf/probdnf in a Female Population with Overactive Bladder Syndrome
Lysanne Campeau, Canada

MP-03.10 Midnight Catheter Removal After Holmium Laser Enucleation of the Prostate: Impact on Voiding Parameters and Hospital Stay
Pankaj Nandkishore Maheshwari, India

MP-03.11 Nationwide Trends in the Age at Orchiopexy in the United States of America
Joseph Ortenber, United States

MP-03.12 Real-world Patients with Prostate Cancer Experience Durable Symptom Relief with the Prostatic Urethral Lift (PUL)
Mark Rochester, United Kingdom

MP-03.13 Sexual Function Outcomes in Patients and Patients' Spouses After Midurethral Sling Procedure for Stress Urinary Incontinence: Data From a Minimum of 9 Years of Follow-up
Phil Hyun Song, Korea, Rep.

MP-03.14 Six-month Outcomes in a Cohort of Patients Undergoing Same-day Trial of Void Using Standard versus MOSES HoLEP for BPH: a Single-center Experience
Loay Abbas, Canada

MP-03.15 Vascular Complications After 3035 Live-donor Renal Transplants: Incidence, Risk Factors, Management and a Focus on Thrombotic and Stenotic Events
Bedeir Ali-El-Dein, Egypt, Arab Rep.

Saturday, November 12

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0700-0800

GA: General Assembly

Room: 522 ABC

0730-0900

IC-14: Instructional Course: Flexible Ureteroscopy in Difficult Anatomy: Decisions and Actions

Room: 518 A
Chair: Ravindra Sabnis, India

0730-0740		Pre-operative Requirements: Anatomy and Instrumentation Vineet Gauhar, Singapore
0740-0755		Diverticular Stones: From Access to Exit Strategy Olivier Traxer, France
0755-0810		Anomalous and Transplant Kidney: Challenges and Solutions Ravindra Sabnis, India
0810-0825		Re-implanted and Reconstructed Ureters: Simplifying a Complicated Approach Saeed Bin Hamri, Saudi Arabia
0825-0835		Take Home Summary: What Every Urologist Must Remember Vineet Gauhar, Singapore
0835-0900		Discussion and Q&A

0730-0900

IS-12: Interactive Session: Day Care and Remote Urology - Is it the Need of the Hour!

Room: 524 A
Co-Chairs: Ashley Cox, Canada / Prem Kumar, India

0730-0900

MC-07: Master Class: Management of Upper Tract Urothelial Cell Carcinoma

Room: 518 C
Co-Chairs: Zeeshan Aslam, United Kingdom / Bhavan Rai, United Kingdom

0730-0735		Welcome and Introductions
0735-0748		Open vs Robotic Nephroureterectomy Sanjai Addla, India
0749-0802		Ideal Technique for Dealing with the Lower End of the Ureter Ginil Kumar, India
0803-0819		Nephron Sparing Strategies in UTUC Joe Philip, United Kingdom
0819-0832		Systemic Options in UTUC - Why and When Mamta Parikh, United States
0832-0900		Discussion and Q&A / Closing Remarks

0730-0900

IS-13: Interactive Session: Research in Urology - Made Easy!

Room: 524 B
Co-Chairs: Peter Black, Canada / Katie Murray, United States

0730-0900

MC-08: Master Class: Management of MIBC – A Guideline Based Approach

Room: 518 B
Co-Chairs: Wassim Kassouf, Canada / Nikhil Vasdev, United Kingdom

0730-0731		Welcome and Introductions
0731-0741		Radical Cystectomy: Clinical Pearls for Optimizing Perioperative Care Sia Daneshmand, United States
0741-0808		Debate: 82y.o male with MIBC cT2N0, multifocal with concomitant CIS
0741-0743		Introduction Khurshid Guru, United States
0743-0753		Open Radical Cystectomy remains the standard for MIBC-Old is Gold Colin Dinney, United States
0753-0803		Robotic Cystectomy is the new Gold Standard for MIBC Anup Kumar, India
0803-0808		Discussant Khurshid Guru, United States
0808-0823		Bladder Sparing Approaches for MIBC Shilpa Gupta, United States
0823-0838		Systemic Options for Advanced Bladder Urothelial Cancer Karima Oualla, Maroc
0838-0900		Interactive Discussion and Closing Remarks

0730-0900

IS-14: Interactive Session: Resident Mentoring Session - SIU Resident Development Programme

Room: 517 CD
Chair: Imogen Patterson, Australia

0800-1600

NURS: 7th SIU Global Nurses' Educational Symposium

Room: 520 B
Co-Chairs: Amparo Gudrun Camacho, United States / Nathalie Maher, Canada

0900-1030

PL-02: Plenary 02

Room: 517 A
Honorary Chairs: Jean de la Rosette, Türkiye / Rajeev Kumar, India

0900-0915		Welcome and SIU Academy Award Presentations Co-Chair: Jean de la Rosette, Türkiye
0915-0930		Confederación Americana de Urología (CAU) Lecture: Endourological Management of Upper Tract TCC - How Have the New Lasers Changed the Management Alejandro Rodriguez, United States
0930-0945		Urological Association of Asia (UAA) Lecture: Transitional Urologic Care Venkatesh Krishnamoorthy, India At the end of the lecture, attendees will be able to: Counsel peers and patients on the importance for transitional care Identify urological and nephrological concerns that require transitional urological care Recognize ongoing barriers to transitional care Determine interventions required to support transitional care
0945-1000		State of the Art Lecture: Advances in Prostate Cancer Immunotherapy Mamta Parikh, United States Learning Objectives: At the end of this lecture, attendees: Will be aware of the currently approved immunotherapy options for patients with prostate cancer. Will be able to summarize research completed to date studying immune checkpoint inhibitor therapy in prostate cancer. Can summarize current clinical research evaluating immunotherapy treatments in prostate cancer patients.
1000-1020		Debate: Laparoscopic/Robotic Pyeloplasty in Infants - Are We There Yet? Moderators Margit Fisch, Germany Anil Takvani, India Pro: Mallikarjuna Reddy, India Con: Luis Braga, Canada
1020-1025		Closing Remarks

1030-1100

Break

Room: To be announced

1100-1230

IC-16: Instructional Course: IBCG Master Class on BCG (and Beyond)

Room: 524 A
Co-Chairs: Roger Buckley, Canada / Ashish M. Kamat, United States

1100-1230

CO-02: Controversies in Urology: Management of Oligometastatic Prostate Cancer

Room: 518 C
Co-Chairs: Sudhir Rawal, India / Derya Tilki, Germany

1100-1102		Welcome and Introductions
1102-1115		Defining Oligometastatic Prostate Cancer- Is Molecular Imaging Required? Noel Clarke, United Kingdom
1115-1128		Role of Radical Prostatectomy in Oligometastatic Prostate Cancer Brian F Chapin, United States
1128-1141		Radiotherapy - Palliative or Radical in Oligometastatic Prostate Cancer Daniel Spratt, United States
1141-1154		Role of Ablation in Oligometastatic Prostate Cancer Rafael Sanchez-Salas, Canada
1154-1207		Current Standard of Care for Oligometastatic Prostate Shilpa Gupta, United States
1207-1230		Interactive Discussion

1100-1230

IC-17: Instructional Course: Urological Care for Transgender Patients

Room: 524 B
Chair: Dmitriy Nikolavsky, United States

1100-1230

IS-15: Interactive Session: Business Strategies in Endourology

Room: 518 B
Co-Chairs: Thomas Chi, United States / Bhaskar K. Somani, United Kingdom / Necole Streeper, United States

1100-1105		Welcome and Introductions
1105-1115		Single Use or Reusable Scope: How to Choose the Right Scope Athanasios (Thanos) Papatsoris, Greece
1115-1125		Lasers in Urolithiasis: TFL vs Holmium Naeem Bhojani, Canada
1125-1135		How to Get a New Procedure Started in your Hospital Ananda Dhanasekaran, United Kingdom
1135-1145		Minimally Invasive Surgical Therapies (MIST) in BPH - Is There a Right Option Rajeev T P, India
1145-1155		Laser Use in BPH – Balancing Cost Versus Efficacy Pankaj Maheshwari, India
1155-1205		Shockwave Lithotripsy – How to Set Up a New Service Ravindra Sabnis, India
1205-1230		Interactive Discussion and Closing Remarks

1100-1230

IS-16: Interactive Session: Seeking Fellowships for Trainees

Room: 518 A
Co-Chairs: Pankaj Joshi, India / Manal Kumar, United Kingdom

1100-1230

JS-03: Joint Session: SIU / Society of Urologic Robotic Surgeons (SURS) Session

Room: 522 ABC
Chair: Wooju Jeong, United States
Honorary Chair: Rajeev Kumar, India

1230-1400

Networking Lunch

Room: Exhibit Hall 517 CD

1245-1400

SYMP-25: Luncheon Symposium - Adjuvant Immunotherapy in Bladder and Kidney Cancers: a New Standard of Care for Our Patients?

Room: 517 B
Co-Chairs: Matthew Galsky, United States / Tian Zhang, United States
Panelists: Umberto Capitanio, Italy / Shilpa Gupta, United States / Wassim Kassouf, Canada

1400-1600

WS-05: Workshop: Newer Treatment Options for Benign Prostatic Enlargement (BPE)

Room: 520 A
Chair: Ananda Dhanasekaran, United Kingdom
Faculty: Dean Elterman, Canada / Kevin Zorn, Canada

1400-1530

CO-03: Controversies in Urology: Use of PSMA PET for Staging and Clinical Trial Enrollment in Prostate Cancer

Room: 518 C
Co-Chairs: Anup Kumar, India / Peter Pinto, United States

1400-1405		Welcome and Introductions
1405-1417		Role of PSMA PET Scans in Primary Staging Raghunath Krishnappa, India
1417-1429		Current Trials in the Role of Radical Prostatectomy in Metastatic PCa Brian F Chapin, United States
1429-1441		Role of PSMA PET in Biochemical Recurrent PCa Damien Bolton, Australia
1441-1453		Theranostics in Prostate Cancer : Established and Evolving Concepts Gagan Prakash, India
1453-1518		Interactive Discussion
1518-1530		Wrap-up and Closing Remarks

1400-1530

IC-18: Instructional Course: Management of Erectile Dysfunction

Room: 518 A
Chair: Mélanie Aubé-Peterkin, Canada

1400-1530

MV-05: Master Videos: Male Incontinence

Room: 518 B
Co-Chairs: Jaspreet S. Sandhu, United States / Suryaprakash Vaddi, India

1400-1530

MP-04: Moderated ePoster Session - Bladder Cancer – Clinical and Basic Science

Room: 524 A
Moderators: Seth Lerner, United States / Petros Sountoulides, Greece

MP-04.01 "En-Bloc Resection" of Bladder Tumour Improves Pathological Staging: an Initial Australian Experience Considering Surgical and Pathological Outcomes
Ramesh Shanmugasundaram, Australia

MP-04.02 A 3-arm Randomized Control Trial to Compare the Efficacy of Recirculant Hyperthermic Intravesical Chemotherapy versus Intravesical BCG versus Conventional Intravesical Mitomycin C Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer
Ankit Sachan, India

MP-04.03 A Randomized Prospective Single Center Study to Compare Outcomes of Intravesical Chemohyperthermia with Mitomycin C vs Intravesical BCG for Intermediate and High Risk Non-Muscle Invasive Bladder cancer(NMIBC)
Karandeep Guleria, India

MP-04.04 Bladder Cancer Associated with Elevated Level of Lead, Cadmium, Aluminum and Zinc: Correlation with Tumor Characteristics and Expression of Fgfr3, Gata3 and Cytokeratin 5/6 Bedeir
Ali-El-Dein, Egypt, Arab Rep.

MP-04.05 Development & Validation of a Method for Detection of Circulating Tumour DNA in Non-Muscle-Invasive Bladder Cancer
Shomik Sengupta, Australia

MP-04.06 En-Bloc-Resection of Bladder Tumors: a Critical Appraisal and Possible Clinical Relevance
Rahim Horuz, Turkey

MP-04.07 Evaluation of the Role of Radical Cystectomy and Lymph Node Dissection in Patients with Non-metastatic Clinically Advanced Lymph Nodal (Cn2/n3) Bladder Cancer: an Analysis From National Cancer Database
Harshit Garg, United States

MP-04.08 Oncological Outcomes of Patients with Node Positive Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: a Multicenter Observational Study of the EAU Young Academic Urologists (Yau) Urothelial Carcinoma Working Group
Gautier Marcq, France

MP-04.10 The Anti-tumor Activity of Prebiotics in Bladder Cancer
Jalal Laaraj, Canada

MP-04.13 Three Year-survival Outcomes After Neoadjuvant Pembrolizumab and Radical Cystectomy: Final Results From the Pure-01 Study
Andrea Necchi, Italy

MP-04.14 Truncated Terminal Ureterectomy in the Treatment of Peri-Ureteral Orifice Bladder Tumors: Report of 15 Cases.
Shengkun Sun, China

MP-04.15 Use of 5- Aminolevulinic Acid and Novel Tp4303 Molecule for the Diagnosis of Bladder Cancer in Voided Urine - a Preliminary Report, with Special Focus on Comparison with Conventional Non-Invasive Urinary Biomarkers
Shoubhik Chandra, India

1400-1745

RF-01: Resident's Forum

Room: 520 CF
Moderators: Pilar Laguna, Türkiye / Lara Rodriguez Sanchez, Spain

RF-01.01 A Comparative Propensity Score-Matched Analysis of Perioperative Outcomes of Laser Enucleation of the Prostate vs Simple Prostatectomy for Benign Prostatic Hyperplasia: Will Approach Affect Morbidity and Mortality Post Prostatectomy?
Zafardjan Dalimov, United States

RF-01.02 Absence of Recurrence and Androgen Deprivation Therapy in More than Half of Patients Treated for High-grade (ISUP Grade 4-5) Prostate Cancers After Radical Prostatectomy: a Case for Treatment Desintensification
Daphnée Bédard-Tremblay, Canada

RF-01.03 Applying the Russell Principle to Restore Urethral Patency in Patients with Fournier's Gangrene. the Importance of Negative Pressure Wound v.a.c.® Therapy in Promoting Tissue Granulation.
Ramón Virasoro, United States

RF-01.04 Are Genital Protectors Meeting Safety Standards? a Laboratory Study Analyzing the Impact Resistance of Genital Protectors
Ghadir Omran, Australia

RF-01.05 Clinical Utility of Prostate Health Index for Detection of Prostate Cancer in Patients with Pi-Rads Version 2 Score 3 Lesion
Hoyoung BAE, Korea, Rep.

RF-01.06 Colonic Perforation in Supine PCNL: a Case Report
Ryan Josef Dela Cruz Tuazon, Philippines

RF-01.07 Complications and Stone-Free Rate According to the Caliber of Percutaneous Nephrolithotomy
Juliusz Jan Szczesniewski Dudzik, Spain

RF-01.08 Concordance Between Biparametric MRI and Radical Prostatectomy Specimen in the Detection of Clinically Significant Prostate Cancer and Staging
Rammah Abdlbagi, United Kingdom

RF-01.09 Evaluation of Incidence of Ureteric Stricture Following Percutaneous Antegrade vs Laparoscopic Removal of Large Upper Ureteric Stones
Thummala Yashaswi, India

RF-01.10 Impact of the Infundibulopelvic Angle in Stone Free Rate for Retrograde Intra Renal Surgery for Renal Lithiasis
Mohamed helmi Tabka, Tunisia

RF-01.11 Impact of Three-Dimensional (3d) Renal Reconstruction on Preoperative Planning for Complex Renal Tumors: a Novel Interactive Web-Based Survey
Raed Azhar, Saudi Arabia

RF-01.12 Investigating the Acute and Late Local Side Effects and Biochemical Control of Patients with Prostate Cancer Treated with Single-Dose High-Dose Rate Brachytherapy Mini
Vasanthamai Sardar, United Kingdom

RF-01.13 Kidney Hydatid Cyst : a Monocentric Study About 11 Cases
Mohamed helmi Tabka, Tunisia

RF-01.14 Microsurgical Testicular Sperm Extraction (MICRO-TESE) Sperm Retreival Rate (Srr) Post Testicular Sperm Aspiration (Tesa)
Ahmad Alshammari, Canada

RF-01.15 Modified Nephrostomy Access Sheath in Minimally Invasive Percutaneous Nephrolithotomy: Complications and Outcomes.
Juliusz Jan Szczesniewski Dudzik, Spain

RF-01.16 Modified Shockwave Propulsion Lithotripsy as a More Effective Method for Treatment of the Renal Lower Pole Stones Compared to Standard SWL.
Karen Arzumanyan, Armenia

RF-01.17 Multimodality Treatment Following Radical Prostatectomy for T3b Prostate Cancer - a Middle Eastern Experience
Jose M. El- Asmar, Lebanon

RF-01.18 Non-Transecting Urethroplasty versus Direct Visual Internal Urethrotomy for Short Segment Non-Traumatic Bulbar Urethral Strictures
Naman Aggarwal, India

RF-01.19 Pediatric Dual Kidney Transplantation
Han-Chung Yang, Taiwan

RF-01.20 Perioperative Outcomes After Laser Enucleation of the Prostate: Comprehensive Analysis of 1693 NSQIP Patients
Zafardjan Dalimov, United States

RF-01.21 Poor Prognostic Factors in Patients with Emphysematous Pyelonephritis, Experience of 20 Years in Tertiary Level Hospital in Mexico City
Ernesto Davila, Mexico

RF-01.22 Quality of Life After 14fr Super-mini Percutaneous Nephrolithotomy: Results From a Tertiary Referral Centre
Thomas Roshan Fonseka, United Kingdom

RF-01.23 Renal Carcinoma: Correlation of Preoperative Computed Tomography Finding with Histopathological Staging: a Retrospective Study
Mohamed helmi Tabka, Tunisia

RF-01.24 Resultant Delays in Stone Surgery Due to the Covid-19 Pandemic and Associated Morbidity Mini
Vasanthamai Sardar, United Kingdom

RF-01.25 Retrograde Intra Renal Surgery (RIRS) versus Shock Wave Lithotripsy (SWL) for Small Lower Pole Renal Stone
Mohamed helmi Tabka, Tunisia

RF-01.27 The Learning Curve for Percutaneous Renal Access in Supine vs Prone Position in a Cadaveric Training Model
José Iván Robles-Torres, Mexico

RF-01.28 The Short Term Oncological Outcome of Intravesical BCG vs Intravesical Gemcitabine/docetaxel Sequential Therapy in NMIBC: a Prospective Randomized Trial
Shiraz Akif Mohd Ziauddin, India

1400-1530

IC-19: Instructional Course: PCNL Tips/Tricks and Pitfalls

Room: 522 ABC
Chair: Athanasios (Thanos) Papatsoris, Greece

1400-1415		How to Optimize the Patient Pre-Op Athanasios (Thanos) Papatsoris, Greece
1415-1420		Q&A
1420-1435		How to Simply Perform Miniaturized PCNL Sanjay Khadgi, Nepal
1435-1440		Q&A
1440-1455		How to Efficiently and Safely Perform Standard PCNL S. K. Pal, India
1455-1500		Q&A
1500-1515		The Do's and the Don'ts in Nightmare Cases: Vote for the Best Option! Mohamad Moussa, Lebanon
1515-1520		Q&A
1520-1530		Discussion and Take Home Messages

1400-1530

MP-05: Moderated ePoster Session - Prostate Cancer – Detection, Screening and Prevention

Room: 524 B
Moderator: Robert Abouassaly, United States

MP-05.01 a Urinary Exosome Assay Interrogating Small Non-coding Rnas Accurately Identifies and Stratifies Prostate Cancer Into Low- Intermediate- or High-risk Disease
Laurence Klotz, Canada

MP-05.02 Assessing the Experience Needed to Tolerably Perform Transperineal Biopsy Under Local Anaesthetic
Anika Jain, Australia

MP-05.03 Clinical Utility of Combining Prostate Health Index and Pi-Rads Version 2 to Improve Detection of Clinically Significant Prostate Cancer
Hoyoung Bae, Korea, Rep.

MP-05.04 Clinical Utility of Prostate Health Index for Detection of Prostate Cancer in Patients with PI-RADS Version 2 Score 3 Lesion
Sangsoo Park, Korea, Rep.

MP-05.05 Comparison of PSA Results Using Abbott Alinity and Siemens Atellica Assays
Anika Jain, Australia

MP-05.06 Comparison of PSA Using Different Assays and Their Impact on MRI Eligibility
Anika Jain, Australia

MP-05.07 Could Youtube Encourage Men on Prostate Checks? a Contemporary Analysis
Simone Morra, Italy

MP-05.08 Effect of Distance to Cancer Centre on Outcomes and Type of Intervention in Prostate Cancer
Walid Shahrour, Canada

MP-05.09 Interreader Agreement with Prostate Imaging Reporting and Data System Version 2.1 to Improve the Detection Rate of Prostate Cancer in MRI/TRUS Software Fusion Prostate Biopsy)
Won Hoon Song, Korea, Rep.

MP-05.10 MRI and PSMA PET Prior to Prostate Biopsy (Mp4 Study)
Anthony-Joe Nassour, Australia

MP-05.11 PSMA PET Guided Metastasis Directed Therapy: Changing the Treatment Paradigm for Oligometastatic Prostate Cancer
Arthur Yim, Australia

MP-05.13 Transgluteal Ga-68 PSMA PET/CT Guided Prostate Biopsy for Diagnosis of Prostate Cancer
Shrawan Kumar Singh, India

MP-05.14 Transperineal Prostate Biopsy Under Local Anaesthesia: Patient Reported Outcomes of Safety and Tolerability
Hadia Khanani, Australia

MP-05.15 Understanding the factors for disparity in prostate cancer- and all-cause mortality associated with Hispanic ethnicity using accelerated lifetime regression models
Harshit Garg, United States

1530-1600

Break

Room: To be announced

1600-1730

IC-20: Instructional Course: Reconstrucción al Rescate: Cuando la Cirugía Primaria Falla / Rescue Reconstruction: When Primary Surgery Fails (COURSE IN SPANISH)

Room: 518 A
Chair: Reynaldo Gómez, Chile

1600-1605		Bienvenida – Welcome Reynaldo Gómez, Chile
1605-1625		Cirugía de Rescate por Enf. De Peyronie – Rescue Surgery After Failed Peyronie’s Treatment Ramon Virasoro, United States
1625-1645		Cirugía de Rescate Tras Sling Uretral Femenino – Rescue Surgery After Failed Female Sling Jessica DeLong, United States
1645-1705		Cirugía de Rescate por Estenosis Vesico-uretral – Rescuing Vesico-urethral Anastomosis Stenosis Reynaldo Gómez, Chile
1705-1730		Preguntas y Discusión – Questions and Discussion

1600-1730

IS-17: Interactive Session: Pediatric Urology for the General Urologist

Room: 518 C
Co-Chairs: Dawn MacLellan, Canada / Mallikarjuna Reddy, India

1600-1730

JS-04: Joint Session: SIU / Society of Genitourinary Reconstructive Surgeons (GURS) Symposium

Room: 522 ABC
Co-Chairs: Francisco E. Martins, Portugal / Kurt McCammon, United States

1600-1730

MV-06: Master Videos: Managing Penile Prosthesis Complications

Room: 518 B
Chair: Melissa Kaufman, United States

1600-1730

MP-06: Moderated ePoster Session - Kidney and Ureteral Cancer – Clinical, Penis/Testis/Urethra: Cancer – Clinical, Stones, Miscellaneous

Room: 524 A
Moderators: Sia Daneshmand, United States / Anup Kumar, India

MP-06.01 A Comparison Among RIRS and MiniPerc for Renal Stones Between 1 and 2 Cm Using Fiber Dust: a RCT
Andrea Pacchetti, Italy

MP-06.02 Do Outcomes of Ureteroscopy and Laser Stone Fragmentation (Ursl) in Patients with Morbid Obesity Match up to Non-obese Patients: Prospective Comparative Analysis over a 10-year Period
Francesco Ripa, United Kingdom

MP-06.03 Do We Follow Guidelines for Shock Wave Lithotripsy for Urolithiasis - a Global Survey
Bulent Erkurt, Turkey

MP-06.04 Do We Need to Deescalate on Total Penectomy - Lessons Learnt From Excess Margin Status and Implications for Utilization of Penile Reconstruction
Gagan Prakash, India

MP-06.05 Early Predictors of Systemic Inflammatory Response Syndrome in Patients Undergoing Percutaneous Nephrolithotomy }
Naman Aggarwal, India

MP-06.06 Extended Venous Thromboembolism Prophylaxis After Retroperitoneal Robot Assisted Partial or Laparoscopic Nephrectomy - is It Necessary?
Louise Paramore, United Kingdom

MP-06.07 Holmium Laser Using Vapor Tunnel Pulse Emission Mode in the Treatment of Guy I Kidney Stones
Pablo Contreras, Argentina

MP-06.08 Percutaneous Nephrolithotomy Access: a Meta-Analysis Comparing Access by Urologist vs Radiologist
Zafardjan Dalimov, United States

MP-06.09 Post-Nephrostomy-Tube Removal Urine Leak After Percutaneous Nephrolithotomy: Does the Calyx of Puncture Make a Difference?
Pankaj Nandkishore Maheshwari, India

MP-06.10 - RESCHEDULED to MP-01 - Friday, November 11 - 1400-1530
Pre-operative Images for Upper Tract Stones - How Old is Too Old?
Ijeoma Chibuzo, United Kingdom

MP-06.11 Robot‑assisted Retroperitoneal Lymph Node Dissection for Post Chemotherapy Residual Mass in Testicular Cancer: Long Term Experience From a Tertiary Care Centre.
Vivek Vasudeo, India

MP-06.12 Short and Intermediate Term Inferior Vena Cava Patency Outcomes in Patients Undergoing Radical Nephrectomy and Venous Tumor Thrombectomy for Renal Cell Carcinoma
Harshit Garg, United States

MP-06.13 Silodosin versus Tamsulosin for Medical Expulsive Therapy of Ureteral Stones: an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hae Do Jung, Korea, Rep.

MP-06.14 Smoking Status Among Cancer Patients by Specialty: a United States Nationwide Representative Analysis
José Ignacio Nolazco, United States

MP-06.15 The Offer of a Testicular Prosthesis Improves Patient Satisfaction Following Orchidectomy: Patient Reported Outcomes From a Tertiary Australian Centre
Daryl Victoria Thompson, Australia

MP-06.16 Efficacy of Narrow Focus versus Wide Focus Shock Wave Lithotripsy in Management of 1-2cm Renal Calculi Using Tri-focal Lithotripsy Machine: First Double-blind Randomized Trial
Yasser Noureldin, Saudi Arabia

1600-1730

MP-07: Moderated ePoster Session - Prostate Cancer - Advanced Disease, Basic Science, Localized Disease, Staging and Miscellaneous

Room: 524 B
Moderators: Hans Peter Schmid, Switzerland / Gokul Vignesh KandaSwamy, United Kingdom

MP-07.01 A Novel Protein-Encoding Circular RNA Ccdc719-15 Inhibits the Progression of Prostate Cancer by up-Regulating Flrt3
Qiong Wang, China

MP-07.02 Comparison of Cardiovascular Event Risk After Androgen Deprivation Therapy Initiation by Drug Dosing Duration
Stuart N. Atkinson, United States

MP-07.03 Comparison of Multiparametric Magnetic Resonance Imaging (mpMRI) and 68Ga-PSMA-11 Positron Emission Tomography/ Computed Tomography (PET/CT) Imaging for Local Staging Prior to Radical Prostatectomy in Patients with Prostate Cancer
Prashant Singh, India

MP-07.04 Control Urologic Postoperative Pain (Cupp) Initiative for Radical Prostatectomies
Abdulla AlAmeeri, United Arab Emirates

MP-07.05 Correlation of Histopathological Extent and Characteristics of Malignancy in the Rarp Specimen, with the Preoperative Simultaneous PSMA PET /MRI Imaging Characteristics.
Rajesh Taneja, India

MP-07.06 Cytor Drives Prostate Cancer Progression via Facilitating AR-V7 Generation and Its Oncogenic Signaling
Jianpeng Yu, China

MP-07.07 Focal Ablation versus Radical Prostatectomy for Intermediate-risk Prostate Cancer: One Year Post- Treatment Interim Analysis of a Randomized Controlled Trial in First 148 Patients.
Eduard Bac, Norway

MP-07.08 Intra-Individual Comparison of Ga-68 PSMA PET/CT with Tc-99 Bone Scan for Detection of Skeletal Metastasis During Prostate Cancer Primary Staging in a Large Cohort
Ramesh Shanmugasundaram, Australia

MP-07.09 Is the Maximum Standardised Uptake Cutoff of Value in Predicting Clinically Significant Prostate Cancer?
Anika Jain, Australia

MP-07.10 New Approaches to Targeting Epigenetic Regulation in Prostate Cancer
Daryl Victoria Thompson, Australia

MP-07.11 Patient Population and Radiation Therapy Type in the Long-term Phase 3 Double-blind, Placebo-controlled Atlas Study of Apalutamide Added to Androgen Deprivation Therapy in High-risk Localized or Locally Advanced Prostate Cancer
Peter Hammerer, Germany

MP-07.12 Relationship Between Androgen Deprivation Therapy and Normal-Tension Glaucoma in Patients with Prostate Cancer: a Nationwide Cohort Study
Jinhyung Jeon, Korea, Rep.

MP-07.13 Single Dose of Dexamethasone Prior to Catheter Removal Decreases the Rate of Urinary Retention After Radical Prostatectomy
Taras Shatylko, Russian Federation

MP-07.14 Substratification of Current National Comprehensive Cancer Network (NCCN) High-risk Prostate Cancer Stratification: a National Cancer Database Analysis
Harshit Garg, United States

MP-07.15 The 17-gene Genomic Assay is Prognostic for Biochemical Failure, Distant Metastasis, and Prostate Cancer Death in Men with Localized Prostate Cancer After Definitive Radiation Therapy
Daniel Canter, United States

MP-07.16 The Utility of Gallium-68 Prostate Specific Membrane Antigen Positron Emission Tomography in Guiding Lymph Node Dissection in Men Undergoing Radical Prostatectomy for Unfavourable Intermediate or High-risk Prostate Cancer
Gavin Wei, Australia

1600-1730

IC-21: Instructional Course: Perioperative Immunotherapy Treatment of Localized Genitourinary Malignancies

Room: 524 C
Chair: Andrea Necchi, Italy

1603-1623		Rationale for the Use of Neoadjuvant and Adjuvant Immunotherapy Strategies in Resectable GU Malignancies Michael Poch, United States
1623-1643		The Landscape of Available Data and Ongoing Trials in the GU Tumors Landscape Andrea Necchi, Italy
1643-1647		The Landscape of Available Data and Ongoing Trials in the GU Tumors Landscape - Part 2 Andrea Necchi, Italy
1643-1703		Practice Management of Multimodal IO Therapy for the Urologists: Focus on Safety Management Philippe E Spiess, United States
1701-1730		Discussion Guided by Faculty Optimal design and endpoints of clinical studies in perioperative settings Patient empowerment and use of patient-driven endpoints for clinical research Shortening the distances between specialists and improving the multidisciplinary management Live web-based involvement of patient advocates (all faculty, with the contribution of people from the BCAN, the KidneyCan foundation, the Prostate Cancer Foundation) Susan Poteat for KidneyCan • Rick Bangs for BCAN

Sunday, November 13

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-0900

MC-09: Master Class: Management of Adrenal Masses

Room: 518 B
Co-Chairs: Rajeev Kumar, India / Neal Rowe, Canada

0730-0735		Welcome and Introductions
0735-0750		Adrenal Incidentalomas - Evaluation and Management Wooju Jeong, United States
0750-0805		Pheochromocytomas - Precautions and Preparation Neal Rowe, Canada
0805-0820		Partial Adrenalectomy - When and How Toshikazu Takeda, Japan
0820-0835		Laparoscopic Adrenalectomy - Technique and Tips Rajeev Kumar, India
0835-0900		Discussion and Q&A / Closing Remarks

0730-0900

IC-22: Instructional Course: Practical Endourology in Resource Restricted Environments

Room: 524 B
Chair: Kymora Scotland, United States

0730-0900

IS-18: Interactive Session: Applied Urodynamics in Adults

Room: 518 C
Co-Chairs: Priyanka Gupta, United States / Arjun Nambiar, United Kingdom / Sanjay Sinha, India

0730-0735		Welcome and Introductions
0735-0755		Building the Foundation Priyanka Gupta, United States Fundamental principles Artifacts Quality control
0755-0815		Indications for Urodynamics Anne P. Cameron, United States Female voiding and storage LUTS Male voiding and storage LUTS Neurogenic LUTD (nLUTD)
0815-0835		Typical Urodynamics Findings Sanjay Sinha, India Urodynamic stress incontinence, ALPP, detrusor overactivity incontinence and cough associated detrusor overactivity in women Dysfunctional voiding, primary bladder neck obstruction, prolapse associated obstruction and underactivity in women Bladder outlet obstruction and underactive detrusor in men Assessing safety of storage in nLUTD, poor compliance, NDO, DLPP, DSD
0835-0900		Interactive Discussion

0730-0900

MC-10: Master Class: Application of Bowel in Reconstructive Urology

Room: 518 A
Co-Chairs: Tohid MS Hossain, Bangladesh / Shrawan Kumar Singh, India

0730-0735		Welcome and Introductions
0735-0748		Bladder Augmentation - Options Amlesh Seth, India
0748-0801		Urinary Neobladder - How I do it? Seth Lerner, United States
0801-0814		Ureteral Replacement Options Girdhar Bora, India
0814-0827		Intracorporeal vs. Extracorporeal Urinary Diversion Khurshid Guru, United States
0827-0900		Interactive Discussion and Closing Remarks

0900-1030

PL-03: Plenary 03

Room: 517 A
Honorary Chairs: Sanjay Kulkarni, India / Rajeev Sood, India

0900-0905		Welcome
0905-0920		Albert-Schweitzer Award Lecture - Benefits of Humanitarian Work and How the Pandemic may have Improved our Training Kurt McCammon, United States
0920-0935		European Association of Urology (EAU) Lecture: Urethral Reconstruction in 2022: An Update with Reference to the EAU Guidelines Christopher R Chapple, United Kingdom
0935-0950		American Urological Association (AUA) Lecture: Penile Cancer Update Curtis Pettaway, United States Learning Objectives: Describe the world wide incidence, mortality, and common risk factors for penile cancer Determine how to select patients with penile cancer for penile preserving treatment Describe characteristics of advanced penile cancer and multimodality treatment approaches
0950-1005		State of the Art Lecture: Assessing Technical Competence in Urologic Surgery Ethan Grober, Canada
1005-1025		Late Breaking Abstracts Pilot Data From the Iroc Randomised Controlled Trial -Robotic -Assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs. Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer Nikhil Vasdev, United Kingdom The Feasibility and Acceptability of a Mobile Application for Men with LUTS/BPH: a Siu Ucare Pilot Study Stavros Gravas, Gravas Active Surveillance for Prostate Cancer in the Era of Magnetic Resonance Imaging and Genomic Testing Vinayak Wagaskar, United States
		Pilot Data From the Iroc Randomised Controlled Trial -Robotic -Assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs. Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer Nikhil Vasdev, United Kingdom
		The Feasibility and Acceptability of a Mobile Application for Men with LUTS/BPH: a Siu Ucare Pilot Study Stavros Gravas, Cyprus
		Active Surveillance for Prostate Cancer in the Era of Magnetic Resonance Imaging and Genomic Testing Vinayak Wagaskar, United States
1025-1030		Closing Remarks

1030-1100

Break

Room: To be announced

1100-1230

CO-04: Controversies in Urology: Controversies in Urinary Stone Management

Room: 518 B
Co-Chairs: Oriol Angerri Feu, Spain / Kymora Scotland, United States

1100-1105		Welcome and Introductions
1105-1117		Managing Residual Stones – When Do I Need to Intervene? Pankaj Maheshwari, India
1117-1129		Intrarenal Temperature and Pressure – Are We Ready for the Primetime? Kandarp Parikh, India
1129-1141		Smart Concept for Ureteroscopy – Creating the Future Platform Bhaskar K. Somani, United Kingdom
1141-1153		Minimally Invasive PCNL – Is Smaller Always Better? Ravindra Sabnis, India
1153-1205		Dusting, Fragmenting or Pop-Corning – Evidence Based Approach for the Best Outcome Kandarp Parikh, India
1205-1230		Interactive Discussion

1100-1230

HT-05: Hot Topics: Rare Genito Urinary Cancers

Room: 518 A
Co-Chairs: Gagan Prakash, India / Philippe E Spiess, United States

1100-1102		Welcome and Introductions
1102-1117		Section I - Penile Cancer
		a. Current Concepts, Practice Patterns and Evidence Curtis Pettaway, United States
		b. Controversies, Ongoing Research and Potential Studies for Future Logan Zemp, United States
1117-1132		Section II - Testicular Cancer
		a. Current Concepts, Practice Patterns and Evidence Karima Oualla, Maroc
		b. Controversies, Ongoing Research and Potential Studies for Future Shilpa Gupta, United States
1132-1147		Section III - Adrenal tumors
		a. Current Concepts, Practice Patterns and Evidence Marshall Strother, United States
		b. Controversies, Ongoing Research and Potential Studies for Future Rakesh Manilal Sharma, India
1147-1202		Section IV - Upper Tract Urothelial Cancer
		a. Current Concepts, Practice Patterns and Evidence Pilar Laguna, Türkiye
		b. Controversies, Ongoing Research and Potential Studies for Future Michael Poch, United States
1202-1209		GSRGT Talk Philippe E Spiess, United States
1209-1230		Discussion and Q&A

1100-1230

IC-24: Instructional Course: Robotic Partial Nephrectomy

Room: 524 B
Chair: Anant Kumar, India

1100-1104		Welcome and Introductions Anant Kumar, India
1104-1119		Indication, contraindication, preoperative work up ,tumour scoring Imaging, Intra operative US ICG, 3 D printing Anup Kumar, India
1119-1134		Simple Partial Nephrectomy, Heminephrectomy No clamping technique Sudhir Rawal, India
1134-1149		Complex Partial Nephrectomy, Hilar and intrarenal Tumour PN in Solitary Kidney Anant Kumar, India
1149-1155		Retroperitoneal PN Ketan Badani, NY
1155-1207		Reproducible Approach to Robotic Partial Nephrectomy: Equalization of Outcomes Across the Tumor Complexity Spectrum Ketan Badani, NY
1207-1230		Discussion and Closing Remarks Anup Kumar, India